Literature DB >> 11754992

Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events.

A J Tenner1.   

Abstract

The complement system is a critical element of the innate immune system recognizing and killing, or targeting for destruction, otherwise pathogenic organisms. In addition to triggering the generation of a membranolytic complex, complement proteins interact with cell surface receptors to promote a local inflammatory response that contributes to the protection and healing of the host. Compelling evidence has been reported that in Alzheimer's Disease complement activation occurs in the brain, and that this contributes to the development of a local inflammatory state that is correlated with cognitive dysfunction. However, recent data suggest that at least some of the complement components have the ability to contribute to neuroprotective pathways. Thus, it is the balance of these seemingly competing events that influences the ultimate state of neuronal function. Knowledge of the unique molecular interactions that occur in the development of Alzheimer's Disease, the functional consequences of those interactions, and the proportional contribution of each element to this disorder, should facilitate the design of effective therapeutic strategies for this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754992     DOI: 10.1016/s0197-4580(01)00301-3

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  30 in total

1.  Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.

Authors:  Ming Li; Rahasson R Ager; Deborah A Fraser; Natalia O Tjokro; Andrea J Tenner
Journal:  Mol Immunol       Date:  2008-04-08       Impact factor: 4.407

2.  Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.

Authors:  Kaori Morimoto; Juri Horio; Haruhisa Satoh; Lucia Sue; Thomas Beach; Seizaburo Arita; Ikuo Tooyama; Yoshihiro Konishi
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 3.  Regulatory mechanisms of nervous systems with glycosphingolipids.

Authors:  Koichi Furukawa; Yuhsuke Ohmi; Yuki Ohkawa; Noriyo Tokuda; Yuji Kondo; Orie Tajima; Keiko Furukawa
Journal:  Neurochem Res       Date:  2011-05-12       Impact factor: 3.996

Review 4.  Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells.

Authors:  Jorge Ghiso; Silvia Fossati; Agueda Rostagno
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice.

Authors:  Paramita Chakrabarty; Carolina Ceballos-Diaz; Amanda Beccard; Christopher Janus; Dennis Dickson; Todd E Golde; Pritam Das
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

6.  Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.

Authors:  Qiaoqiao Shi; Saba Chowdhury; Rong Ma; Kevin X Le; Soyon Hong; Barbara J Caldarone; Beth Stevens; Cynthia A Lemere
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

7.  Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.

Authors:  Yuhsuke Ohmi; Orie Tajima; Yuki Ohkawa; Atsushi Mori; Yasuo Sugiura; Keiko Furukawa; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

8.  C3aR inhibition reduces neurodegeneration in experimental lupus.

Authors:  A Jacob; L Bao; J Brorson; R J Quigg; J J Alexander
Journal:  Lupus       Date:  2009-11-09       Impact factor: 2.911

9.  Presenilin/gamma-Secretase and Inflammation.

Authors:  Carlos A Saura
Journal:  Front Aging Neurosci       Date:  2010-05-18       Impact factor: 5.750

10.  Expression of complement system components during aging and amyloid deposition in APP transgenic mice.

Authors:  Julia Reichwald; Simone Danner; Karl-Heinz Wiederhold; Matthias Staufenbiel
Journal:  J Neuroinflammation       Date:  2009-11-17       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.